Globe Newswire (Mon, 27-Jul 1:05 PM ET)
Globe Newswire (Mon, 20-Jul 3:46 PM ET)
Cosmos Health Share Buyback Expands to 5.11 Million Shares; Continues Open Market Repurchases
Globe Newswire (Fri, 17-Jul 2:55 PM ET)
Globe Newswire (Thu, 16-Jul 1:15 PM ET)
Cosmos Health Share Buyback Surpasses 4.5 Million Shares; Continues Open Market Repurchases
Globe Newswire (Wed, 15-Jul 2:15 PM ET)
Cosmos Health Share Buyback Expands to 4.49 Million Shares; Continues Open Market Repurchases
Globe Newswire (Tue, 14-Jul 2:40 PM ET)
Cosmos Health Share Buyback Reaches 4.36 Million Shares; Continues Open Market Repurchases
Globe Newswire (Mon, 13-Jul 3:00 PM ET)
Globe Newswire (Mon, 13-Jul 1:00 PM ET)
Cosmos Health Launches Subscription Model
Globe Newswire (Fri, 10-Jul 10:55 AM ET)
Cosmos Health Expands Share Buyback to 4.14 Million Shares; Continues Open Market Repurchases
Globe Newswire (Thu, 9-Jul 3:45 PM ET)
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.
Cosmos Health trades on the NASDAQ stock market under the symbol COSM.
As of August 14, 2026, COSM stock price was flat at $0.21 with 127,590 million shares trading.
COSM has a beta of 2.92, meaning it tends to be more sensitive to market movements. COSM has a correlation of 0.15 to the broad based SPY ETF.
COSM has a market cap of $13.04 million. This is considered a Sub-Micro Cap stock.
Last quarter Cosmos Health reported $18 million in Revenue and -$.06 earnings per share. This fell short of revenue expectation by $-4 million and missed earnings estimates by -$.05.
In the last 3 years, COSM traded as high as $2.05 and as low as $.16.
The top ETF exchange traded funds that COSM belongs to (by Net Assets): VXF.
COSM has underperformed the market in the last year with a return of -73.9%, while the SPY ETF gained +21.9%. In the last 3 month period, COSM fell short of the market, returning -30.7%, while SPY returned +5.1%. However, in the most recent 2 weeks COSM has outperformed the stock market by returning +4.9%, while SPY returned +4.9%.
COSM support price is $.19 and resistance is $.22 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that COSM shares will trade within this expected range on the day.
